Kraneshares MSCI All China Health Care Index ETF (KURE) closed at $18.74 on November 10, 2026, down 0.8% from the previous close, on volume of 17,722 shares (30-day average 102,613).
Data as of November 10, 2026.
No press releases found.
Asian stocks rally on US tech rebound; China trade surplus hits $105B in October
Seeking Alpha News (Tue, 10-Nov 1:06 AM ET)
China's October trade surplus reaches $105.3B as exports jump 35.2% and imports surge 41.6%
Seeking Alpha News (Tue, 10-Nov 12:30 AM ET)
China inflation misses estimates as food prices extend decline
Seeking Alpha News (Mon, 9-Nov 2:37 AM ET)
Asian markets plunge; broad equity selloff follows tech turmoil in US
Seeking Alpha News (Fri, 6-Nov 1:13 AM ET)
Asian stocks diverge, BoJ signals further hikes and Australia's trade surplus surges
Seeking Alpha News (Thu, 5-Nov 1:42 AM ET)
KURE seeks to measure the performance of MSCI China All Shares Health Care 10/40 Index. The Index is a free float adjusted market capitalization weighted index designed to track the equity market performance of Chinese companies engaged in the health care sector. The securities in the Index include all types of publicly issued shares of Chinese issuers, which are listed in Mainland China, Hong Kong and United States. Issuers eligible for inclusion must be classified under the Global Industry Classification Standard as engaged in the healthcare sector. The issuers included in the Underlying Index may include small-cap, mid-cap and large-cap companies.
Kraneshares MSCI All China Health Care Index ETF trades on the ARCA stock market under the symbol KURE.
As of November 10, 2026, KURE stock price declined to $18.74 with 17,722 million shares trading.
KURE has a beta of 0.79, meaning it tends to be less sensitive to market movements. KURE has a correlation of 0.13 to the broad based SPY ETF.
KURE has a market cap of $115.25 million. This is considered a Micro Cap stock.
In the last 3 years, KURE traded as high as $21.88 and as low as $12.91.
KURE has underperformed the market in the last year with a return of +3.4%, while SPY returned +12.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in KURE shares. However, KURE has outperformed the market in the last 3 month and 2 week periods, returning +1.1% and +4.6%, while SPY returned -2.8% and -2.0%, respectively. This indicates KURE has been having a stronger performance recently.
KURE support price is $18.52 and resistance is $19.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KURE shares will trade within this expected range on the day.
